Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MEA115666: A Multi-centre, Open-label, Long Term Safety Study of Mepolizumab in Asthmatic Subjects Who Participated in the MEA112997 Trial

NCT01691859 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT01691859
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01691859 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MEA115666: A Multi-centre, Open-label, Long Term Safety Study of Mepolizumab in Asthmatic Subjects Who Participated in the MEA112997 Trial
Lead sponsor
GlaxoSmithKline
Phase
Phase 3
Overall status
Completed
Start date
September 28, 2012
Completion date
May 31, 2017
Enrollment
347 (actual)
Sites
64

Conditions

As the registry lists them; a condition with its own page is linked.

asthma